secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0001493152-24-002835
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa Pharmaceuticals to effect 1-for-20 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split ratio 1-for-20, effective 12:01 a.m. ET Jan. 22, 2024.
- Outstanding shares reduce from ~24.6M to ~1.2M.
- No fractional shares; rounding up to nearest whole share.
- Intended to regain compliance with Nasdaq $1 minimum bid price.
- Stock continues trading under symbol PCSA with new CUSIP 74275C304.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224002835/0001493152-24-002835-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224002835/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-002835

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer